Location · Delaware
Clinical trials recruiting in Delaware
54 recruiting studies have at least one site in Delaware; 29 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Delaware.
54 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Dover, DE + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
Prolaio
- Location
- Wilmington, DE + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Newark, DE + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingHealthy volunteers
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
N-Power Medicine
- Location
- Dover, DE + 6 other US sites
- Eligibility basics
- Ages 18–120
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Renibus Therapeutics, Inc.
- Location
- Newark, DE + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
Angitia Incorporated Limited
- Location
- Wilmington, DE + 5 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
An Open Label Study Assessing REN Treatment in Headache Management in Temporomandibular Disorders
Theranica
- Location
- Newark, DE + 3 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca
- Location
- Wilmington, DE + 70 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
AstraZeneca
- Location
- Wilmington, DE + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
Trevi Therapeutics
- Location
- Wilmington, DE + 3 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- Wilmington, DE + 136 other US sites
- Eligibility basics
- Ages 45–99
- RecruitingPhase 2/Phase 3
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Merck Sharp & Dohme LLC
- Location
- Wilmington, DE + 7 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
GlaxoSmithKline
- Location
- Wilmington, DE + 36 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Tyra Biosciences, Inc
- Location
- Wilmington, DE + 11 other US sites
- Eligibility basics
- Ages 3–10
- RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
- Location
- Wilmington, DE + 21 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 4
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
CorMedix Therapeutics
- Location
- Wilmington, DE + 5 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Novo Nordisk A/S
- Location
- Wilmington, DE + 42 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Kaneka Medical America LLC
- Location
- Wilmington, DE + 9 other US sites
- Eligibility basics
- Up to age 21
- Recruiting
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Kaneka Medical America LLC
- Location
- Wilmington, DE + 9 other US sites
- Eligibility basics
- Up to age 75
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Wilmington, DE + 18 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Newark, DE + 54 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Versono Medical Ltd
- Location
- Wilmington, DE + 5 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Newark, DE + 112 other US sites
- Eligibility basics
- Ages 45+
- Recruiting
A Study to Evaluate a New Semi-rigid Brace, the RESILIENT Brace by Thinks Works, as a Way to Limit Curve Worsening in Kids With Idiopathic Scoliosis.
Thinks Works, PBC
- Location
- Wilmington, DE
- Eligibility basics
- Ages 9–16